Immunotherapy Administration: Oncology Nursing Society Recommendations .
As the use of immunotherapeutic agents increases in single-agent and multimodality treatment regimens, oncology nurses face the challenge of administering and caring for patients receiving new and unique agents. Oncology Nursing Society clinical staff and clinical nurses collaborated to produce a set of recommendations to educate nurses involved with the monitoring of patients receiving immunotherapy on administration procedures and safe handling of these agents to ensure patient and staff safety and to reduce risk of error. The recommendations are meant to provide clinical nurses with a framework on which to build policies and procedures for administering new treatment modalities. .
Oncology Nursing Society (ONS), Pittsburgh, PA.
Kathleen
K
Wiley
Oncology Nursing Society (ONS), Pittsburgh, PA.
Kristine B
KB
LeFebvre
Memorial Sloan Kettering Cancer Center.
Lisa
L
Wall
Memorial Sloan Kettering Cancer Center.
Abigail
A
Baldwin-Medsker
University of Texas MD Anderson Cancer Center.
Kim
K
Nguyen
University of Texas MD Anderson Cancer Center.
Lisa
L
Marsh
Children's Hospital of Philadelphia.
Diane
D
Baniewicz
D000970:Antineoplastic Agents / Q000592:standards* / Q000627:therapeutic use*; D002983:Clinical Competence; D004509:Education, Nursing, Continuing / Q000458:organization & administration; D006801:Humans; D007167:Immunotherapy / Q000451:nursing / Q000592:standards*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009741:Nursing Staff, Hospital / Q000193:education*; D009859:Oncology Nursing / Q000592:standards*; D017410:Practice Guidelines as Topic; D017751:Safety Management / Q000592:standards*; D012956:Societies, Nursing
D000970:Antineoplastic Agents
drug therapy; healthcare policies; safe-handling procedures ; treatment modalities